Last reviewed · How we verify
NCT05954689
Femoral Artery Block for Reduction of Tourniquet Induced Hypertension
NA trial testing Femoral artery block in Tourniquets in 50 participants. Status unknown.
29 February 2024
Quick facts
| Lead sponsor | Hospital da Luz, Portugal |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 50 |
| Start date | 10 July 2023 |
| Primary completion | 29 February 2024 |
| Estimated completion | 31 May 2024 |
Drugs / interventions tested
- Femoral artery block
Conditions studied
- Tourniquets — all drugs for Tourniquets →
- Anesthesia, Conduction — all drugs for Anesthesia, Conduction →
- Anesthetics, Local — all drugs for Anesthetics, Local →
- Hypertension — all drugs for Hypertension →
Sponsor
Hospital da Luz, Portugal
Who can join
18 and older, any sex, with Tourniquets or Anesthesia, Conduction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A randomised controlled trial to assess the impact of femoral artery block on the incidence of tourniquet hypertension in patients receiving cruciate ligament surgery with \> 30 minutes of tourniquet under combined anaesthesia (balanced general anaesthesia and femoral nerve blocks).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05954689
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tourniquets
Currently open trials in the same condition.
- NCT07412925 — Impact Tourniquet Conservative Placenta Accreta Neonatal APGAR · NA · recruiting
Other Hospital da Luz, Portugal trials
Trials by the same sponsor.
- NCT06702150 — Nursing Model and Health Outcomes of Elderly People with Multimorbidity: a Quasi-experimental Study · NA · completed
- NCT06782204 — Variability of Sulfotransferase Activity in Humans: an Approach to Improve Predictive Drug Response Part II: Analysis of · Phase 1 · completed
- NCT03182595 — Variability of Sulfotransferase 1A1 Activity in Humans: an Approach to Improve Predictive Drug Response - Part I: Analys · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05954689 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital da Luz, Portugal
- Last refreshed: 20 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05954689.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing